The Clinical Effects of Cognitive Behavior Therapy Combined with Ziprasidone in the Treatment of Schizophrenia

HE Jianjun

Abstract：Objective To observe and analyze the effect of cognitive behavior therapy combined with ziprasidone in the treatment of schizophrenia.Methods 98 schizophrenia patients were chosen from our hospital, and they were divided into the experimental group and the control group.The experimental group patients were treated with cognitive behavior therapy combined with ziprasidone, while patients in the control group were only treated by ziprasidone .Thus comparative observation of compliance of the two groups of patients and clinical effect were made.Results It was found out that in the comparative observation that 1 patient of the experimental group refused the treatment, and 9 cases passively implementing, which was significantly lower than that of the control group.There are 39 cases of compliance in the experimental group, which was significantly higher than that of the control group (13 cases).All these figures have statistical significance (P<0.05).After a period of treatment, the total effective rate of the patients (91.84%) in the ex-perimental group was significantly higher than the control group ( 59.18%) .Such difference was also statistically significant ( P<0.05 ) .Conclusion Schizophrenia is a kind of serious mental disease with unknown causes .Clinical treatment of combining oral zi-prasidone with cognitive behavioral therapy can significantly improve the clinical efficacy and patient compliance .